Skip to main content
Convatec Group PLC logo

Convatec Group PLC — Investor Relations & Filings

Ticker · CTEC ISIN · GB00BD3VFW73 LEI · 213800LS272L4FIDOH92 IL Manufacturing
Open in API
Filings indexed 499 across all filing types
Latest filing 2016-10-26 Regulatory Filings
Country GB United Kingdom
Listing IL CTEC

About Convatec Group PLC

https://www.convatecgroup.com/

Convatec is a global medical products and technologies company focused on developing and marketing solutions for the management of chronic conditions. The company holds leading market positions in its four core franchises: Advanced Wound Care, which includes products for acute and chronic wounds; Ostomy Care, providing devices for people with stomas; Continence and Critical Care, offering solutions for bladder and bowel management; and Infusion Care, which supplies devices for subcutaneous drug delivery, primarily for insulin-dependent diabetes. Its products are designed to improve patient outcomes, prevent infection, protect at-risk skin, and reduce the total cost of care for healthcare providers and patients globally.

Recent filings

Filing Released Lang Actions
Issuer Document
Regulatory Filings Classification · 98% confidence The document text is an electronic transmission disclaimer preceding a document described explicitly as a 'Prospectus' for ConvaTec Group Plc, dated 26 October 2016. It details the proposed offer of ordinary shares, admission to the Official List of the UK Financial Conduct Authority (FCA) and trading on the London Stock Exchange. A prospectus is a key document required for public offerings of securities. Since this document relates to the offering and admission of shares, it is fundamentally related to capital raising or financing activities. While a prospectus can sometimes be part of a larger filing like a 10-K or an IPO document, the context here—an offer of shares and the document being a Prospectus approved by the FCA—most closely aligns with a Capital/Financing Update (CAP) or potentially a document related to a major share issue (SHA). Given the focus on the 'Offer' of shares and the document being the formal 'Prospectus' for that offer, 'CAP' (Capital/Financing Update) is the most appropriate classification for the underlying offering document being introduced, as it details the terms of the capital raise. If this were a standard regulatory filing announcement, RPA might apply, but the content is the core offering document itself (the Prospectus).
2016-10-26 English
[change-account-reference-date-company-current-extended] made_up_date=2016-12-30, new_date=2016-12-31
Regulatory Filings
2016-10-11 English
[accounts-balance-sheet]
Regulatory Filings
2016-10-10 English
[change-account-reference-date-company-current-shortened] made_up_date=2017-09-30, new_date=2016-12-30
Regulatory Filings
2016-10-05 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.